Anandamide deficiency and heightened neuropathic pain in aged mice

Neuropharmacology

Volumn 71, Issue , 2013, Pages 204-215

  Bishay, Philipp ^a   Häussler, Annett ^a   Lim, Hee Young ^a   Oertel, Bruno ^a   Galve Roperh, Ismael ^b   Ferreirós, Nerea ^a   Tegeder, Irmgard ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aging; Anandamide 2 Arachidonoylglycerol; Cannabinoid receptor; Cyclooxygenase; Endocannabinoids; Fatty acid amide hydrolase; Inhibitory control; Nociception; Pain; R flurbiprofen

Indexed keywords

ANANDAMIDE; CYCLOOXYGENASE 1; CYTOCHROME P450 2D6; ENDOCANNABINOID; FATTY ACID AMIDASE; FLURBIPROFEN;

AEROBIC METABOLISM; AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFICACY; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE INJURY; SPINAL CORD; SPINAL GANGLION; THALAMUS; UPREGULATION;

AGING; AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BRAIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; CYTOCHROME P-450 CYP2D6; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ENZYME INDUCTION; FLURBIPROFEN; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURALGIA; PERIPHERAL NERVES; POLYUNSATURATED ALKAMIDES; SPINAL CORD; STEREOISOMERISM;

EID: 84878150547     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.03.021     Document Type: Article

References (60)

1. N. Agarwal, P. Pacher, I. Tegeder, F. Amaya, C.E. Constantin, G.J. Brenner, T. Rubino, C.W. Michalski, G. Marsicano, K. Monory, K. Mackie, C. Marian, S. Batkai, D. Parolaro, M.J. Fischer, P. Reeh, G. Kunos, M. Kress, B. Lutz, C.J. Woolf, and R. Kuner Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors Nat. Neurosci. 10 2007 870 879
2. O. Albayram, J. Alferink, J. Pitsch, A. Piyanova, K. Neitzert, K. Poppensieker, D. Mauer, K. Michel, A. Legler, A. Becker, K. Monory, B. Lutz, A. Zimmer, and A. Bilkei-Gorzo Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging Proc. Natl. Acad. Sci. U. S. A. 108 2011 11256 11261
3. M. Ates, M. Hamza, K. Seidel, C.E. Kotalla, C. Ledent, and H. Guhring Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test Eur. J. Neurosci. 17 2003 597 604
4. P. Bishay, H. Schmidt, C. Marian, A. Haussler, N. Wijnvoord, S. Ziebell, J. Metzner, M. Koch, T. Myrczek, I. Bechmann, R. Kuner, M. Costigan, F. Dehghani, G. Geisslinger, and I. Tegeder R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids PLoS ONE 5 2010 e10628
5. D. Bouhassira, O. Chassany, J. Gaillat, T. Hanslik, O. Launay, C. Mann, C. Rabaud, O. Rogeaux, and C. Strady Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice Pain 153 2012 342 349
6. H.B. Bradshaw, S.H. Lee, and D. McHugh Orphan endogenous lipids and orphan GPCRs: a good match Prostaglandins Other Lipid Mediat. 89 2009 131 134
7. D.R. Charest, and B.G. Kenny Radicular pain caused by synovial cyst: an underdiagnosed entity in the elderly? J. Neurosurg. 92 2000 57 60
8. S. Chiechio, M. Zammataro, M.E. Morales, C.L. Busceti, F. Drago, R.W.T. Gereau, A. Copani, and F. Nicoletti Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain Mol. Pharmacol. 75 2009 1014 1020
9. J.R. Clapper, G. Moreno-Sanz, R. Russo, A. Guijarro, F. Vacondio, A. Duranti, A. Tontini, S. Sanchini, N.R. Sciolino, J.M. Spradley, A.G. Hohmann, A. Calignano, M. Mor, G. Tarzia, and D. Piomelli Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism Nat. Neurosci. 13 2010 1265 1270
10. I. Decosterd, and C.J. Woolf Spared nerve injury: an animal model of persistent peripheral neuropathic pain Pain 87 2000 149 158
11. K.C. Duggan, D.J. Hermanson, J. Musee, J.J. Prusakiewicz, J.L. Scheib, B.D. Carter, S. Banerjee, J.A. Oates, and L.J. Marnett (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Nat. Chem. Biol. 7 2011 803 809
12. D.A. Edwards, L. Zhang, and B.E. Alger Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus Proc. Natl. Acad. Sci. U. S. A. 105 2008 8142 8147
13. P.K. Forsell, A. Brunnstrom, M. Johannesson, and H.E. Claesson Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases Lipids 47 2012 781 791
14. L. Gatta, F. Piscitelli, C. Giordano, S. Boccella, A. Lichtman, S. Maione, and V. Di Marzo Discovery of prostamide F2alpha and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability PLoS ONE 7 2012 e31111
15. J.R. Ghilardi, C.I. Svensson, S.D. Rogers, T.L. Yaksh, and P.W. Mantyh Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia J. Neurosci. 24 2004 2727 2732
16. G. Godlewski, L. Offertaler, J.A. Wagner, and G. Kunos Receptors for acylethanolamides - GPR55 and GPR119 Prostaglandins Other Lipid Mediat. 89 2009 105 111
17. A.I. Gulyas, B.F. Cravatt, M.H. Bracey, T.P. Dinh, D. Piomelli, F. Boscia, and T.F. Freund Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala Eur. J. Neurosci. 20 2004 441 458
18. B.D. Heifets, V. Chevaleyre, and P.E. Castillo Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin Proc. Natl. Acad. Sci. U. S. A. 105 2008 10250 10255
19. M.N. Hill, R.J. McLaughlin, B. Bingham, L. Shrestha, T.T. Lee, J.M. Gray, C.J. Hillard, B.B. Gorzalka, and V. Viau Endogenous cannabinoid signaling is essential for stress adaptation Proc. Natl. Acad. Sci. U. S. A. 107 2010 9406 9411
20. J.R. Hochman, L. Gagliese, A.M. Davis, and G.A. Hawker Neuropathic pain symptoms in a community knee OA cohort Osteoarthritis Cartilage 19 2011 647 654
21. S. Holt, and C.J. Fowler Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH Naunyn Schmiedebergs Arch. Pharmacol. 367 2003 237 244
22. A. Jayamanne, R. Greenwood, V.A. Mitchell, S. Aslan, D. Piomelli, and C.W. Vaughan Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models Br. J. Pharmacol. 147 2006 281 288
23. M.D. Jhaveri, D. Richardson, I. Robinson, M.J. Garle, A. Patel, Y. Sun, D.R. Sagar, A.J. Bennett, S.P. Alexander, D.A. Kendall, D.A. Barrett, and V. Chapman Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain Neuropharmacology 55 2008 85 93
24. M. Kaczocha, A. Hermann, S.T. Glaser, I.N. Bojesen, and D.G. Deutsch Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase J. Biol. Chem. 281 2006 9066 9075
25. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol. Rev. 89 2009 309 380
26. W.E. Kaufmann, P.F. Worley, J. Pegg, M. Bremer, and P. Isakson COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc. Natl. Acad. Sci. U. S. A. 93 1996 2317 2321
27. J. Kim, and B.E. Alger Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus Nat. Neurosci. 7 2004 697 698
28. S.G. Kinsey, J.Z. Long, B.F. Cravatt, and A.H. Lichtman Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms J. Pain 11 2010 1420 1428
29. S.G. Kinsey, J.Z. Long, S.T. O'Neal, R.A. Abdullah, J.L. Poklis, D.L. Boger, B.F. Cravatt, and A.H. Lichtman Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain J. Pharmacol. Exp. Ther. 330 2009 902 910
30. 2+ levels and transmitter release in the hippocampus Br. J. Pharmacol. 151 2007 551 563
31. C. Maihofner, I. Tegeder, C. Euchenhofer, D. deWitt, K. Brune, R. Bang, W. Neuhuber, and G. Geisslinger Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord Neuroscience 101 2000 1093 1108
32. Y. Marchalant, H.M. Brothers, G.J. Norman, K. Karelina, A.C. DeVries, and G.L. Wenk Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis Neurobiol. Dis. 34 2009 300 307
33. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S.C. Azad, M.G. Cascio, S.O. Gutierrez, M. van der Stelt, M.L. Lopez-Rodriguez, E. Casanova, G. Schutz, W. Zieglgansberger, V. Di Marzo, C. Behl, and B. Lutz CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
34. F. Massa, G. Mancini, H. Schmidt, F. Steindel, K. Mackie, C. Angioni, S.H. Oliet, G. Geisslinger, and B. Lutz Alterations in the hippocampal endocannabinoid system in diet-induced obese mice J. Neurosci. 30 2010 6273 6281
35. K. Monory, F. Massa, M. Egertova, M. Eder, H. Blaudzun, R. Westenbroek, W. Kelsch, W. Jacob, R. Marsch, M. Ekker, J. Long, J.L. Rubenstein, S. Goebbels, K.A. Nave, M. During, M. Klugmann, B. Wolfel, H.U. Dodt, W. Zieglgansberger, C.T. Wotjak, K. Mackie, M.R. Elphick, G. Marsicano, and B. Lutz The endocannabinoid system controls key epileptogenic circuits in the hippocampus Neuron 51 2006 455 466
36. S.E. O'Sullivan Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br. J. Pharmacol. 152 2007 576 582
37. S. Patel, B.F. Cravatt, and C.J. Hillard Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala Neuropsychopharmacology 30 2005 497 507
38. S. Patel, P.J. Kingsley, K. Mackie, L.J. Marnett, and D.G. Winder Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala Neuropsychopharmacology 34 2009 2699 2709
39. S. Patel, C.T. Roelke, D.J. Rademacher, W.E. Cullinan, and C.J. Hillard Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis Endocrinology 145 2004 5431 5438
40. N. Puente, Y. Cui, O. Lassalle, M. Lafourcade, F. Georges, L. Venance, P. Grandes, and O.J. Manzoni Polymodal activation of the endocannabinoid system in the extended amygdala Nat. Neurosci. 14 2011 1542 1547
41. B.G. Ramirez, C. Blazquez, T. Gomez del Pulgar, M. Guzman, and M.L. de Ceballos Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation J. Neurosci. 25 2005 1904 1913
42. C.E. Rockwell, and N.E. Kaminski A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes J. Pharmacol. Exp. Ther. 311 2004 683 690
43. F. Rodriguez de Fonseca, I. Del Arco, F.J. Bermudez-Silva, A. Bilbao, A. Cippitelli, and M. Navarro The endocannabinoid system: physiology and pharmacology Alcohol Alcohol. 40 2005 2 14
44. C.A. Rouzer, and L.J. Marnett Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways Chem. Rev. 111 2011 5899 5921
45. T.A. Samad, K.A. Moore, A. Sapirstein, S. Billet, A. Allchorne, S. Poole, J.V. Bonventre, and C.J. Woolf Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity Nature 410 2001 471 475
46. J. Scholz, and C.J. Woolf The neuropathic pain triad: neurons, immune cells and glia Nat. Neurosci. 10 2007 1361 1368
47. M. Shukuri, M. Takashima-Hirano, K. Tokuda, T. Takashima, K. Matsumura, O. Inoue, H. Doi, M. Suzuki, Y. Watanabe, and H. Onoe In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester J. Nucl. Med. 52 2011 1094 1101
48. N.T. Snider, A.M. Kornilov, U.M. Kent, and P.F. Hollenberg Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides J. Pharmacol. Exp. Ther. 321 2007 590 597
49. N.T. Snider, M.J. Sikora, C. Sridar, T.J. Feuerstein, J.M. Rae, and P.F. Hollenberg The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6 J. Pharmacol. Exp. Ther. 327 2008 538 545
50. R.P. Talens, K. Christensen, H. Putter, G. Willemsen, L. Christiansen, D. Kremer, H.E. Suchiman, P.E. Slagboom, D.I. Boomsma, and B.T. Heijmans Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs Aging Cell 11 2012 694 703
51. M. Tsuda, K. Inoue, and M.W. Salter Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia Trends Neurosci. 28 2005 101 107
52. K. Van Acker, D. Bouhassira, D. De Bacquer, S. Weiss, K. Matthys, H. Raemen, C. Mathieu, and I.M. Colin Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics Diabetes Metab. 35 2009 206 213
53. S.I. van Nes, C.G. Faber, R.M. Hamers, O. Harschnitz, M. Bakkers, M.C. Hermans, R.J. Meijer, P.A. van Doorn, and I.S. Merkies Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies J. Neurol. Neurosurg. Psychiatry 79 2008 832 834
54. S. Wang, and K.M. Albers Behavioral and cellular level changes in the aging somatosensory system Ann. N. Y. Acad. Sci. 1170 2009 745 749
55. S. Wang, B.M. Davis, M. Zwick, S.G. Waxman, and K.M. Albers Reduced thermal sensitivity and Nav1.8 and TRPV1 channel expression in sensory neurons of aged mice Neurobiol. Aging 27 2006 895 903
56. W.J. Wechter, D. Kantoci, E.D. Murray Jr., D.D. Quiggle, D.D. Leipold, K.M. Gibson, and J.D. McCracken R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer Cancer Res. 57 1997 4316 4324
57. A. Witting, L. Walter, J. Wacker, T. Moller, and N. Stella P2X7 receptors control 2-arachidonoylglycerol production by microglial cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 3214 3219
58. Y.J. Won, H.L. Puhl 3rd, and S.R. Ikeda Molecular reconstruction of mGluR5a-mediated endocannabinoid signaling cascade in single rat sympathetic neurons J. Neurosci. 29 2009 13603 13612
59. D.F. Woodward, Y. Liang, and A.H. Krauss Prostamides (prostaglandin- ethanolamides) and their pharmacology Br. J. Pharmacol. 153 2008 410 419
60. T.L. Yaksh, D.M. Dirig, C.M. Conway, C. Svensson, Z.D. Luo, and P.C. Isakson The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1 J. Neurosci. 21 2001 5847 5853